MRI in myopathy

Neurologic Clinics

Volumn 22, Issue 3, 2004, Pages 509-538

  Lovitt, Steven ^a,d   Marden, Franklin A ^b   Gundogdu, Betul ^c   Ostrowski, Mary L ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTERIOR HORN CELL DISEASE; DIAGNOSTIC PROCEDURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE LOCATION; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; HYPERTRANSLUCENT LUNG; LABORATORY TEST; METABOLIC DISORDER; MIYOSHI MYOPATHY; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE HYPERTROPHY; MUSCULAR DYSTROPHY; MYOPATHY; MYOSITIS; MYOTONIA; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

DIAGNOSIS, DIFFERENTIAL; FUNCTIONAL LATERALITY; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NEUROMUSCULAR DISEASES; SYNDROME;

EID: 2942718850     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2004.03.008     Document Type: Review

References (78)

1. Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology Committee on Research. J Neurol Sci 1999;169:2-12.
2. World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House "Therapeutic Trials in ALS" Workshop Contributors. J Neurol Sci 1995;129(Suppl):1-10.
3. Dahlbom K, Lindberg C, Oldfors A. Inclusion body myositis: morphological clues to correct diagnosis. Neuromuscul Disord 2002;12:853-7.
4. Collins MP, Mendell JR, Periquet MI, et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 2000;55:636-43.
5. Berquist TH. MRI of the musculoskeketal system. Philadelphia: Lippincott Williams and Wilkins; 2000.
6. Schweitzer ME, Fort J. Cost-effectiveness of MR imaging in evaluating polymyositis. AJR Am J Roentgenol 1995;165:1469-71.
7. Hernandez RJ, Keim DR, Sullivan DB, Chenevert TL, Martel W. Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis. J Pediatr 1990;117: 546-50.
8. Pitt AM, Fleckenstein JL, Greenlee RG Jr, Burns DK, Bryan WW, Haller R. MRI-guided biopsy in inflammatory myopathy: initial results. Magn Reson Imaging 1993;11:1093-9.
9. Lampa J, Nennesmo I, Einarsdottir H, Lundberg I. MRI guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease. Ann Rheum Dis 2001;60: 423-6.
10. Hernandez RJ, Sullivan DB, Chenevert TL, Keim DR. MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. AJR Am J Roentgenol 1993;161:359-66.
11. Chapman S, Southwood TR, Fowler J, Ryder CA. Rapid changes in magnetic resonance imaging of muscle during the treatment of juvenile dermatomyositis. Br J Rheumatol 1994; 33:184-6.
12. Park JH, Vital TL, Ryder NM, et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994;37:736-46.
13. Fujino H, Kobayashi T, Goto I, Onitsuka H. Magnetic resonance imaging of the muscles in patients with polymyositis and dermatomyositis. Muscle Nerve 1991;14:716-20.
14. Fraser DD, Frank JA, Dalakas M, Miller FW, Hicks JE, Plotz P. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991;18:1693-700.
15. Keim DR, Hernandez RJ, Sullivan DB. Serial magnetic resonance imaging in juvenile dermatomyositis. Arthritis Rheum 1991;34:1580-4.
16. Park JH, Vansant JP, Kumar NG, et al. Dermatomyositis: correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease. Radiology 1990;177:473-9.
17. Vencovský J, Jarošová K, Machácek S, et al. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 2000;29:95-102.
18. Alexanderson H, Stenström CH, Jenner G, Lundberg I. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 2000;29:295-301.
19. Nyberg P, Wikman AL, Nennesmo I, Lundberg I. Increased expression of interleukin 1a and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000;27:4.
20. Fraser DD, Frank JA, Dalakas MC. Inflammatory myopathies: MR imaging and spectroscopy. Radiology 1991;179:341-2.
21. May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 2000;20: S295-315.
22. Reimers CD, Schedel H, Fleckenstein JL, et al. Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults. J Neurol 1994;241:306-14.
23. Stiglbauer R, Graninger W, Prayer L, et al. Polymyositis: MRI-appearance at 1.5 T and correlation to clinical findings. Clin Radiol 1993;48:244-8.
24. el-Noueam KI, Schweitzer ME, Bhatia M, Bartolozzi AR. The utility of contrast-enhanced MRI in diagnosis of muscle injuries occult to conventional MRI. J Comput Assist Tomogr 1997;21:965-8.
25. Fleckenstein JL, Watumull D, Conner K, et al. Denervated human skeletal muscle: MRI evaluation. Radiology 1993;187:213-8.
26. Bendszus M, Koltzenburg M. Visualization of denervated muscle by gadolinium-enhanced MRI. Neurology 2001;57:1709-11.
27. Bendszus M, Wessig C, Reiners K, Bartsch AJ, Solymosi L, Koltzenberg M. MR imaging in the differential diagnosis of neurogenic foot drop. AJNR Am J Neuroradiol 2003;24: 1283-9.
28. Bulcke JAL, Baert AL. Clinical and radiological aspects of myopathies. New York: Springer-Verlag; 1982. p. 89-95.
29. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998;85:115-22.
30. Roman WJ, Fleckenstein J, Stray-Gundersen J, Alway SE, Peshock R, Gonyea WJ. Adaptations in the elbow flexors of elderly males following resistance training. Spine 1993; 74:750-4.
31. Scola RH, Werneck LC, Ramos CS, Pasquini R, Graf H, Arruda WO. Amyloidotic muscle pseudohypertrophy: case report. Arq Neuropsiquiatr 2001;59(3-A):582-6.
32. Pestronk A. Available at: www.neuro.wustl.edu/neuromuscular. Accessed December 1, 2003.
33. Gelinas D. Conceptual approach to diagnostic delay in ALS: a United States perspective. Neurology 1999;3(8 Suppl 5):S17-9[discussion: S20-1].
34. Bryan WW, Reisch JS, McDonald G, Herbelin LL, Barohn RJ, Fleckenstein JL. Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis. Neurology 1998; 51:110-3.
35. Fischer AQ, Carpenter DW, Hartlage PL, Carroll JE, Stephens S. Muscle imaging in neuromuscular disease using computerized real-time sonography. Muscle Nerve 1988;11: 270-5.
36. Suput D, Zupan A, Sepe A, Demsar F. Discrimination between neuropathy and myopathy by use of magnetic resonance imaging. Acta Neurol Scand 1993;87:118-23.
37. Schalke BCG, Hofmann E, Reiners K, Kaiser W. Neuropathies and motor neuron diseases. Anatomy of the lower extremity. In: Fleckenstein JL, Reimers C, Crues JV, editors. Muscle imaging in health and disease. New York: Springer-Verlag; 1996. p. 203-13.
38. Petersilge CA, Pathria MN, Gentili A, Recht MP, Resnick D. Denervation hypertrophy of muscle: MR features. J Comput Assist Tomogr 1995;19:596-600.
39. Chan WP, Liu GC. MR imaging of primary skeletal muscle diseases in children. AJR Am J Roentgenol 2002;179:989-97.
40. Lam WW, Chan H, Chan YL, Fung JW, So NM, Metreweli C. MR imaging in amyopathic dermatomyositis. Acta Radiol 1999;40:69-72.
41. Stonecipher MR, Jorizzo JL, Monu J, Walker F, Sutej PG. Dermatomyositis with normal muscle enzyme concentrations. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound. Arch Dermatol 1994;130:1294-9.
42. Fujino H, Kobayashi T, Goto I, Onitsuka H. Magnetic resonance imaging of the muscles in patients with polymyositis and dermatomyositis. Muscle Nerve 1994;14:716-20.
43. Lamminen AE. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 1990;63:946-50.
44. Fraser DD, Frank JA, Dalakas M, Miller FW, Hicks JE, Plotz P. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991;18:1693-700.
45. Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol 2002;29:1897-906.
46. Amato AA, Gronseth GS, Jackson CE, et al. Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 1996;40:581-6.
47. Mercuri E, Pichiecchio A, Counsell S, et al. A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 2002;6:305-7.
48. Kimball AB, Summers RM, Turner M, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000;43:1866-73.
49. Bartlett ML, Ginn L, Beitz L, Villaba ML, Plotz P, Bacharach SL. Quantitative assessment of myositis in the thigh msucles using magnetic resonance imaging. Magn Reson Imaging 1999;17:183-99.
50. Adams EM, Pucino F, Yarboro C, et al. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures. J Rheumatol 1999;26:352-60.
51. Schalke B, Hofmann E, Kaiser K. Disorders of the neuromuscular junction. In: Fleckenstein JL, Reimers C, Crues JV, editors. Muscle imaging in health and disease. New York: Springer-Verlag; 1996. p. 215-8.
52. Brooke M. A clinician's view of neuromuscular diseases. Baltimore: Williams and Wilkins; 1996.
53. Reimers CD, Vogl TJ. Myotonic dystrophy. In: Fleckenstein JL, Reimers C, Crues JV, editors. Muscle imaging in health and disease. New York: Springer-Verlag; 1996. p. 237-43.
54. Day JW, Ricker K, Jacobsen JF. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-64.
55. Munsat TL. A standardized forearm ischemic exercise test. Neurology 1970;20:1171-8.
56. Sinkeler SPT, Daanen HAM, Wevers RA, et al. The relation between blood lactate and ammonia in ischemic handgrip exercise. Muscle Nerve 1985;8:523-7.
57. Cinnamon J, Slonim AE, Black KS, Gorey MT, Scuderi DM, Hyman RA. Evaluation of the lumbar spine in patients with glycogen storage disease: CT demonstration of patterns of paraspinal muscle atrophy. Am J Neuroradiol 1991;12:1099-103.
58. Kaminski P, Walker PM. Endocrine myopathies. In: Fleckenstein JL, Reimers C, Crues JV, editors. Muscle imaging in health and disease. New York: Springer-Verlag; 1996. p. 269-81.
59. Horber FF, Scheidegger JR, Grunig BE, Frey FJ. Thigh muscle mass and function in patients treated with glucocorticoids. Eur J Clin Invest 1985;15:302-7.
60. Abbs S, Bobrow M. Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene. J Med Genet 1992;29:191-6.
61. Gillard EF, Chamberlain JS, Murphy EG, et al. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet 1989;45:507-20.
62. Hu XY, Ray PN, Murphy EG, et al. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotype genotype correlation. Am J Hum Genet 1990;46:682-95.
63. Roberts RG, Bobrow M, Bentley DR. Point mutations in the dystrophin gene. Proc Natl Acad Sci USA 1992;89:2331-5.
64. Yau SC, Roberts RG, Bobrow M, Mathew CG. Direct diagnosis of carriers of point mutations in Duchenne muscular dystrophy. Lancet 1993;341:273-5.
65. Mendell JR, Buzin CH, Feng J, et al. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology 2001;57:645-50.
66. Bennett RR, Dunnen J, O'Brien KF, Darras BT, Kunkel LM. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2001;2:17.
67. Marden FA, Connolly AM, Siegel MJ, Rubin DA. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MRI. Program and abstracts of the 55th Annual Meeting of the American Academy of Neurology; March 29-April 5, 2003; Honolulu, HI. Neurology 2003;60 (Suppl 1):A509.
68. Carpenter S, Karpati G. Pathology of skeletal muscle. 2nd edition. Oxford (UK): Oxford University Press; 2001.
69. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16: 193-208.
70. Fleckenstein JL. MRI of neuromuscular disease: the basics. Semin Musculoskelet Radiol 2000;4:393-419.
71. Mercuri E, Counsell S, Allsop J, et al. Selective muscle involvement on magnetic resonance imaging in autosomal dominant Emery-Dreifuss muscular dystrophy. Neuropediatrics 2002;33:10-4.
72. Griggs R, Mendell J, Miller R. Evaluation and treatment of myopathies. Philadelphia: F.A. Davis; 1995.
73. Lamminen AE, Tanttu JI, Sepponen RE, et al. Magnetic resonance of diseased skeletal muscle: combined T1 measurement and chemical shift imaging. Br J Radiol 1990;63:591-6.
74. Ikeda K, Kinoshita M, Iwasaki Y, et al. Unusual fatty infiltration of the soleus muscle in a patient with congenital nemaline myopathy: fat-suppression muscle MRI. Intern Med 2002;41:237-40.
75. Lamminen A, Pihko H. Congenital myopathies. In: Fleckenstein JL, Reimers C, Crues JV, editors. Muscle imaging in health and disease. New York: Springer-Verlag; 1996. p. 245-52.
76. Mercuri E, Sewry C, Brown SC, Muntoni F. Congenital muscular dystrophies. Semin Pediatr Neurol 2002;9:120-31.
77. Mercuri E, Cini C, Pichiecchio A, et al. Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 2003;13: 554-8.
78. Mercuri E, Cini C, Counsell S, et al. Muscle MRI findings in a three-generation family affected by Bethlem myopathy. Eur J Paediatr Neurol 2002;6:309-14.